Medicare Enrolled
Dr. Thein Htay, M.D.
Nuclear Cardiology Physician · Alhambra, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Htay from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Htay?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Htay
Dr. Thein Htay is a nuclear cardiology physician in Alhambra, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Htay performed 3,711 Medicare services across 1,410 unique beneficiaries.
Between the years covered by Open Payments, Dr. Htay received a total of $18,220 from 53 pharmaceutical and/or device companies across 918 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nuclear cardiology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Htay is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 46% volume in CA
$18,220 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,711
Medicare services
Top 46% in CA for nuclear cardiology physician
1,410
Unique beneficiaries
$55
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~195 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Adenosine injection, 1 mg Administration of a 1 mg dose of adenosine medication. This code is specifically for adenosine and excludes adenosine phosphate compounds. |
1,154 | $0 | $8 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
683 | $106 | $165 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
654 | $12 | $45 |
| Thallium-201 diagnostic injection A radioactive thallium-201 injection used for diagnostic imaging, with dosage measured in millicuries. |
484 | $39 | $181 |
| Technetium Tc-99m tetrofosmin diagnostic injection A diagnostic injection of Technetium Tc-99m tetrofosmin used for imaging studies. |
121 | $76 | $200 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
119 | $398 | $650 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
116 | $45 | $95 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
105 | $175 | $525 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
95 | $77 | $125 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
81 | $30 | $75 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
44 | $138 | $245 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
28 | $56 | $165 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
16 | $176 | $350 |
| Ultrasound of leg arteries or grafts An imaging test that uses sound waves to create pictures of the blood vessels in the legs or any surgical grafts present. |
11 | $216 | $350 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
5.0% high complexity
52.1% medium
42.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$18,220
Total received (2018-2024)
Avg $2,603/year across 7 years
Top 8% in CA for nuclear cardiology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
53
Companies
918
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$18,059 (99.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$161 (0.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,261
2023
$2,257
2022
$2,241
2021
$2,677
2020
$1,965
2019
$2,818
2018
$4,001
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$474
Janssen Pharmaceuticals, Inc
$182
Bayer Healthcare Pharmaceuticals Inc.
$178
ABBVIE INC.
$169
Boehringer Ingelheim Pharmaceuticals, Inc.
$159
Actelion Pharmaceuticals US, Inc.
$147
Mylan Specialty L.P.
$109
Madrigal Pharmaceuticals
$109
Kiniksa Pharmaceuticals International, plc
$78
Novartis Pharmaceuticals Corporation
$74
Medtronic, Inc.
$73
Amgen Inc.
$63
Abbott Laboratories
$59
Esperion Therapeutics, Inc.
$52
E.R. Squibb & Sons, L.L.C.
$48
AIMMUNE THERAPEUTICS, INC.
$48
Lexicon Pharmaceuticals, Inc.
$47
IRONWOOD PHARMACEUTICALS, INC
$45
GlaxoSmithKline, LLC.
$43
ABIOMED
$24
SCPHARMACEUTICALS INC.
$23
Novo Nordisk Inc
$21
VIVUS LLC
$21
Merck Sharp & Dohme LLC
$15
Top 3 companies account for 36.9% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$2,308
Amgen Inc.
$2,106
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,238
Janssen Pharmaceuticals, Inc
$1,136
GlaxoSmithKline, LLC.
$990
Novartis Pharmaceuticals Corporation
$855
SANOFI-AVENTIS U.S. LLC
$623
AbbVie Inc.
$541
Esperion Therapeutics, Inc.
$531
Bayer HealthCare Pharmaceuticals Inc.
$520
ABBVIE INC.
$508
Abbott Laboratories
$480
E.R. Squibb & Sons, L.L.C.
$434
Radius Health, Inc.
$425
Amarin Pharma Inc.
$392
Bayer Healthcare Pharmaceuticals Inc.
$367
Regeneron Healthcare Solutions, Inc.
$325
Merck Sharp & Dohme LLC
$295
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$285
PFIZER INC.
$273
Mylan Specialty L.P.
$253
Gilead Sciences, Inc.
$247
Ironwood Pharmaceuticals, Inc
$233
Actelion Pharmaceuticals US, Inc.
$225
Lilly USA, LLC
$221
Sunovion Pharmaceuticals Inc.
$219
Takeda Pharmaceuticals U.S.A., Inc.
$200
Novo Nordisk Inc
$191
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$175
Lexicon Pharmaceuticals, Inc.
$168
Nestle HealthCare Nutrition Inc.
$167
AbbVie, Inc.
$158
Kowa Pharmaceuticals America, Inc.
$144
Madrigal Pharmaceuticals
$109
Medtronic, Inc.
$93
VIVUS LLC
$87
Kiniksa Pharmaceuticals International, plc
$78
Avanir Pharmaceuticals, Inc.
$70
Allergan Inc.
$63
Merck Sharp & Dohme Corporation
$62
CVRx, Inc.
$55
AIMMUNE THERAPEUTICS, INC.
$48
Relypsa, Inc.
$46
Synergy Pharmaceuticals Inc
$45
IRONWOOD PHARMACEUTICALS, INC
$45
ARBOR PHARMACEUTICALS, INC.
$40
ARALEZ PHARMACEUTICALS US INC.
$28
ABIOMED
$24
SCPHARMACEUTICALS INC.
$23
Lundbeck LLC
$22
Vifor Pharma, Inc.
$18
MEDICOMP INC
$15
Amryt Pharma Holdings Ltd
$14
Top 3 companies account for 31.0% of all-time payments
Associated products mentioned in payments ›
AIRSUPRA · ANORO · ANORO ELLIPTA · AVEIR · Aimovig · Amitiza · Arcalyst · BEVESPI AEROSPHERE · BREO · BREZTRI · BREZTRI AEROSPHERE · BRILINTA · BROVANA · BYSTOLIC · Barostim Neo System · CAMZYOS · CARDIAC MONITOR · CHANTIX · CONFIRM RX · CREON · Confirm Rx · Corlanor · Creon · ELIQUIS · ENTRESTO · Edarbi · FARXIGA · FUROSCIX · GALLANT · INVOKANA · Impella · Inpefa · JANUVIA · JARDIANCE · JOT DX · JUXTAPID · Kerendia · LEQVIO · LINQ II · LINZESS · LOKELMA · LONHALA MAGNAIR · LYRICA · LifeVest · Linzess · Livalo · MICRA · MULTAQ · Merlin Connectivity and Remote · Micra · Mitra Clip system · Motegrity · NEXLETOL · NORTHERA · NUEDEXTA · Nanostim Leadleas Pacemaker · OPSUMIT · OPSUMIT MACITENTAN · Ozempic · PANCREAZE · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Prolia · RESMETIROM · Repatha · Rybelsus · SPIRIVA · STEGLATRO · STIOLTO RESPIMAT · SYMBICORT · TRADJENTA · TRELEGY ELLIPTA · TRULANCE · TRULICITY · Trulance · Tymlos · UPTRAVI · UTIBRON · Uloric · VERQUVO · VIBERZI · VYNDAQEL · Vascepa · Veltassa · Verquvo · XARELTO · XIFAXAN · YUPELRI · Yupelri · ZENPEP · ZONTIVITY
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 8% for nuclear cardiology physician in CA.
Geographic Context
Nuclear cardiology physicians within 10 mi
9
Per 100K population
0.1
County median income
$87,760
Nearest hospital
ALHAMBRA HOSPITAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Htay is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 8% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Htay experienced with adenosine injection, 1 mg?
Based on Medicare claims data, Dr. Htay performed 1,154 adenosine injection, 1 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Htay receive payments from pharmaceutical companies?
Yes. Dr. Htay received a total of $18,220 from 53 companies across 918 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Htay's costs compare to other nuclear cardiology physicians in Alhambra?
Dr. Htay's average Medicare payment per service is $55. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Htay) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Nuclear Cardiology Physicians in Alhambra
Browse nuclear cardiology physicians in Alhambra ranked by procedure volume and transparency data.
Highest volume
Top Nuclear Cardiology Physicians in CA
Nuclear cardiology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Nuclear Cardiology Physicians in CA
Which CA nuclear cardiology physicians receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology